These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 13233636)

  • 21. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.
    RATNOFF OD; DAVIE EW; MALLETT DL
    J Clin Invest; 1961 May; 40(5):803-19. PubMed ID: 13739760
    [No Abstract]   [Full Text] [Related]  

  • 22. [ON THE ORIGIN OF THE ERYTHROCYTIC THROMBOPLASTIC FACTOR].
    KUZNIK BI; NAUMOV AD
    Vopr Med Khim; 1964; 10():140-4. PubMed ID: 14231597
    [No Abstract]   [Full Text] [Related]  

  • 23. PLASMA THROMBOPLASTIN ANTECEDENT (FACTOR XI) IN THE NEONATE.
    HILGARTNER MW; SMITH CH
    J Pediatr; 1965 Apr; 66():747-52. PubMed ID: 14271366
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).
    Ratnoff OD
    J Lab Clin Med; 1972 Nov; 80(5):704-10. PubMed ID: 4673237
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway.
    He R; Xiong S; He X; Liu F; Han J; Li J; He S
    Thromb Haemost; 2001 Jun; 85(6):1055-9. PubMed ID: 11434684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of plasma thromboplastin antecedent (factor XI): studies on mechanism of inhibition.
    Goldsmith GH; Silverman P
    J Lab Clin Med; 1985 Sep; 106(3):279-85. PubMed ID: 3875671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bleeding due to deficiency of plasma thromboplastin antecedent (PTA) and plasma thromboplastin component (PTC): report of nine cases.
    STEG RF; GORES RJ; THOMPSON JH; OWEN CA
    Oral Surg Oral Med Oral Pathol; 1960 Jun; 13():671-7. PubMed ID: 13834027
    [No Abstract]   [Full Text] [Related]  

  • 28. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
    Saito H
    J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma thromboplastin antecedent (PTA) deficiency and oral surgery.
    MCGOVERN JJ; TRIEGER N
    Oral Surg Oral Med Oral Pathol; 1957 Jan; 10(1):55-62. PubMed ID: 13400480
    [No Abstract]   [Full Text] [Related]  

  • 30. Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.
    Harpel PC
    J Clin Invest; 1971 Oct; 50(10):2084-90. PubMed ID: 5165598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On the age-dependent activity of the plasms thromboplastin antecedent (PTA, factor XI)].
    Künzer W; Schulz P
    Ann Paediatr; 1965; 205(2):155-60. PubMed ID: 5898601
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation method for plasma thromboplastic activity; clinical physiological applications].
    DE VRIES A; SHAFRIR E
    Rev Hematol; 1952; 7(4):481-94. PubMed ID: 13048104
    [No Abstract]   [Full Text] [Related]  

  • 33. The thromboplastin generation test; some practical modifications and study of the rôle of factors V and VII on the formation of plasma thromboplastin.
    VERSTRAETE M; VANDENBROUCKE J
    Acta Med Scand; 1956 Jun; 155(1):37-48. PubMed ID: 13339280
    [No Abstract]   [Full Text] [Related]  

  • 34. The inflammatory process in acute gouty arthritis. II. The presence of Hageman factor and plasma thromboplastin antecedent in synovial fluid.
    Kellermeyer RW; Breckenridge RT
    J Lab Clin Med; 1966 Mar; 67(3):455-60. PubMed ID: 5910152
    [No Abstract]   [Full Text] [Related]  

  • 35. Cold promoted activation of factor VII. IV. Relation to the coagulation system.
    Gjonnaess H
    Thromb Diath Haemorrh; 1972 Oct; 28(2):194-205. PubMed ID: 4639653
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of intermediates of extrinsic clotting on purified factor XI: factor VII and/or thromboplastin.
    Schiffman S; Markland FS
    Thromb Res; 1975 Mar; 6(3):273-9. PubMed ID: 234640
    [No Abstract]   [Full Text] [Related]  

  • 37. [Factor XIIa-inhibited diluted thromboplastin time can reflect coagulation process].
    He S; Xiong S; He R; He X; Liu F; Han J; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2000 Mar; 21(3):118-21. PubMed ID: 11876967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Factor XI (plasma thromboplastin antecedent) in the full-term newborn infant and the suckling].
    Schettini F; Violante N; Lattanzi E; Paganetti G
    Boll Soc Ital Biol Sper; 1967 May; 43(10):532-5. PubMed ID: 6056664
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on a third plasma factor in thromboplastin formation].
    BELLER FK; MAMMEN E
    Klin Wochenschr; 1955 Feb; 33(7-8):155-6. PubMed ID: 14354889
    [No Abstract]   [Full Text] [Related]  

  • 40. [Individualization of a third plasmatic factor of thromboplastin (plasma thromboplastin antecedent) the deficiency of which causes a hemorrhagic disease similar to hemophilia].
    TROPEANO L
    Prog Med (Napoli); 1953 Jun; 9(11):333-6. PubMed ID: 13074294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.